Lymphoma and Dermatitis

Summary:

Dermatitis is found among people with Lymphoma, especially for people who are male, 60+ old.

The study analyzes which people have Dermatitis with Lymphoma. It is created by eHealthMe based on reports of 13 people who have Lymphoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Lymphoma?

Lymphoma (cancer that begins in immune system cells) is found to be associated with 961 drugs and 1,015 conditions by eHealthMe. Check the latest studies of Lymphoma.

What is Dermatitis?

Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it) is found to be associated with 1,548 drugs and 1,231 conditions by eHealthMe. Check the latest studies of Dermatitis.



On Jul, 17, 2026

13 people who have Lymphoma and Dermatitis are studied.

Would you have Dermatitis when you have Lymphoma?

Gender of people who have Lymphoma and experienced Dermatitis *:

  • female: 12.5 %
  • male: 87.5 %

Age of people who have Lymphoma and experienced Dermatitis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 16.67 %
  • 60+: 83.33 %

Common co-existing conditions for these people *:

  1. Urination - Excessive Volume: 2 people, 15.38%
  2. Hypersensitivity: 2 people, 15.38%
  3. Angioimmunoblastic T-Cell Lymphoma (mature t-cell cancer of the blood or lymph vessel): 2 people, 15.38%
  4. Aortic Dilatation: 2 people, 15.38%
  5. Breast Cancer: 2 people, 15.38%
  6. Cardiotoxicity (damage to the heart muscle): 2 people, 15.38%
  7. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 15.38%
  8. Gout (uric acid crystals building up in the body): 2 people, 15.38%
  9. Tricuspid Valve Incompetence (inefficient heart valve): 2 people, 15.38%
  10. Hepatitis B: 2 people, 15.38%

Common drugs taken by these people *:

  1. Gemcitabine: 2 people, 15.38%
  2. Lentinan: 2 people, 15.38%
  3. Bisoprolol Fumarate: 2 people, 15.38%
  4. Calcium Aspartate: 2 people, 15.38%
  5. Cyclophosphamide: 2 people, 15.38%
  6. Dexamethasone Acetate: 2 people, 15.38%
  7. Dexrazoxane: 2 people, 15.38%
  8. Doxorubicin Hydrochloride: 2 people, 15.38%
  9. Entecavir: 2 people, 15.38%
  10. Estazolam: 2 people, 15.38%

Common symptoms for these people *:

  1. White Blood Cell Count Increased: 2 people, 15.38%
  2. Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 15.38%
  3. Blood Bilirubin Increased: 2 people, 15.38%
  4. Blood Lactate Dehydrogenase Increased: 2 people, 15.38%
  5. Febrile Neutropenia (fever with reduced white blood cells): 2 people, 15.38%
  6. Gamma-Glutamyltransferase Increased: 2 people, 15.38%
  7. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 2 people, 15.38%
  8. Hypokalemia (low potassium): 2 people, 15.38%
  9. White Blood Cell Count Decreased: 2 people, 15.38%
  10. Mucosal Inflammation (infection of mucous membrane): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Dermatitis?

- Check whether Dermatitis is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Dermatitis:

All the conditions that are associated with Dermatitis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Dermatitis and Lymphoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: